New England journal endorses institute's proposals for FDA
BMJ 2006; 333 doi: https://doi.org/10.1136/bmj.333.7572.772 (Published 12 October 2006) Cite this as: BMJ 2006;333:772- Janice Tanne
- New York
The United States faces a “mounting public health crisis in drug safety, and definitive action must be taken” to revitalise the Food and Drug Administration, said Jeffrey Drazen, editor of the New England Journal of Medicine in an editorial that was also signed by two of the journal's senior editors.
The FDA has been politicised, and “this trend must be stopped,” says the editorial, which was published online on 9 October (http://www.nejm.org/, doi:10.1056/NEJMe068237). The FDA's decisions about the nation's drug supply “should be based solely on scientific evidence.”
The FDA has “critical issues of …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.